Triple-negative breast cancer: recent treatment advances

Triple-negative breast cancer (TNBC) is a breast cancer subtype renowned for its capacity to affect younger women, metastasise early despite optimal adjuvant treatment and carry a poor prognosis. Neoadjuvant therapy has focused on combinations of systemic agents to optimise pathological complete res...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergin, Alice R T, Loi, Sherene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681627/
https://www.ncbi.nlm.nih.gov/pubmed/31448088
http://dx.doi.org/10.12688/f1000research.18888.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681627/
https://www.ncbi.nlm.nih.gov/pubmed/31448088
http://dx.doi.org/10.12688/f1000research.18888.1

Ejemplares similares